Patent Assignment
Reel/Frame 044867/0815
Merger
Recorded: 2017-12-13
Pages: 4
Assignor
NEUROVANCE, INC.
Executed: 2017-11-30
Assignee
OTSUKA AMERICA PHARMACEUTICAL, INC.
2440 RESEARCH BLVD., ROCKVILLE, MARYLAND, 20850
Covered Properties
(20)
Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
Application:
11/493,431 →
Publication:
US 2007/0082940
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Application:
12/334,432 →
Publication:
US 2009/0233978
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation and Use to Treat Neuropsychiatric Disorders
Application:
13/207,199 →
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/907,921 →
Publication:
US 2014/0206740
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/751,169 →
Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
Application:
13/528,940 →
Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters
Application:
13/334,066 →
Novel Methods
Application:
61/913,886 →
Methods of Treating Binge Eating Disorder
Application:
15/646,869 →
Publication:
US 2018/0008575
Novel Methods
Application:
62/360,956 →
Crystalline Compounds
Crystalline Compounds
Crystalline Compounds
Application:
62/181,174 →
Novel 1-aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Methods of Treating Fragile X Associated Disorders, Adhd, and Autism Spectrum Disorder
Crystalline Compounds
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 19, 2007
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019578/0394 →
Assignment of Assignor's Interest
Aug 19, 2007
From: SKOLNICK, PHIL; CHEN, ZHENGMING
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 019713/0936 →
Assignment of Assignor's Interest
Dec 22, 2011
From: MCKINNEY, ANTHONY ALEXANDER; BYMASTER, FRANK
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 027437/0683 →
Formation and Reorganization Agreement
Dec 29, 2011
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 027464/0279 →
Merger
Dec 29, 2011
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 027457/0641 →
Assignment of Assignor's Interest
Dec 17, 2013
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 031801/0414 →
Assignment of Assignor's Interest
Dec 17, 2013
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031801/0867 →
Merger
Dec 17, 2013
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 031801/0663 →
Corrective Assignment to Correct the State for Assignee Previously Recorded on Reel 031801 Frame 0867. Assignor(S) Hereby Confirms the Change from New Jersey to Massachusetts.
Dec 27, 2013
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031996/0881 →
Assignment of Assignor's Interest
Jan 10, 2014
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 031945/0082 →
Assignment of Assignor's Interest
Jan 10, 2014
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 031945/0115 →
Merger
Jan 10, 2014
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 031945/0119 →
Change of Name
Feb 20, 2014
From: DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 032258/0937 →
Assignment of Assignor's Interest
Feb 20, 2014
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 032260/0071 →
Assignment of Assignor's Interest
Feb 20, 2014
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 032258/0128 →
Assignment of Assignor's Interest
Jan 22, 2015
From: MCKINNEY, ANTHONY; BYMASTER, FRANK
To: NEUROVANCE, INC.
Reel/Frame 034791/0696 →
Assignment of Assignor's Interest
Jan 22, 2015
From: BYMASTER, FRANK; MCKINNEY, ANTHONY ALEXANDER
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 034791/0008 →
Assignment of Assignor's Interest
Jan 22, 2015
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 034791/0384 →
Assignment of Assignor's Interest
Aug 3, 2015
From: MCKINNEY, ANTHONY; GENTILE, FRANK; HSU, TIMOTHY; BYMASTER, FRANKLIN
To: NEUROVANCE, INC.
Reel/Frame 036239/0262 →
Assignment of Assignor's Interest
Aug 25, 2016
From: MCKINNEY, ANTHONY; GENTILE, FRANK; HSU, TIMOTHY; BYMASTER, FRANKLIN
To: NEUROVANCE, INC.
Reel/Frame 039544/0312 →
Assignment of Assignor's Interest
Oct 28, 2016
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 040512/0162 →
Assignment of Assignor's Interest
Feb 24, 2017
From: KUSUKUNTLA, VENKAT
To: NEUROVANCE, INC.
Reel/Frame 041366/0184 →
Assignment of Assignor's Interest
Feb 24, 2017
From: BYMASTER, FRANKLIN; PISKORSKI, WALTER; MCKINNEY, ANTHONY ALEXANDER
To: NEUROVANCE, INC.
Reel/Frame 041366/0048 →
Assignment of Assignor's Interest
Feb 24, 2017
From: YANG, YONGLAI; SMOLENSKAYA, VALERIYA; ENGERS, DAVID A
To: AMRI SSCI, LLC
Reel/Frame 041365/0848 →
Assignment of Assignor's Interest
Feb 24, 2017
From: FLEITZ, FRED J
To: NEUROVANCE, INC.
Reel/Frame 041366/0342 →